Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143825 |
| CAS No | NA |
| Mol.F. | C20H40N6O10 |
| Mol.Wt. | 524.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143826 |
| CAS No | NA |
| Mol.F. | C20H40N6O10 |
| Mol.Wt. | 524.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143827 |
| CAS No | NA |
| Mol.F. | C20H39N7O9 |
| Mol.Wt. | 521.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143828 |
| CAS No | NA |
| Mol.F. | C21H42N6O8 : C19H38N6O8 : C20H40N6O8 : C21H41N7O9 : C19H36N6O8 : C20H40N6O10 |
| Mol.Wt. | 506.6 : 478.5 : 492.6 : 535.6 : 476.5 : 524.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143829 |
| CAS No | NA |
| Mol.F. | C27H35N3O6S |
| Mol.Wt. | 529.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143830 |
| CAS No | NA |
| Mol.F. | C14H20N2O4 |
| Mol.Wt. | 280.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143831 |
| CAS No | NA |
| Mol.F. | C8H14N2O2 |
| Mol.Wt. | 170.21 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143832 |
| CAS No | NA |
| Mol.F. | C20H20N4O3 |
| Mol.Wt. | 364.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143833 |
| CAS No | 2624134-88-7 |
| Mol.F. | C5H8N2O4 |
| Mol.Wt. | 160.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143834 |
| CAS No | NA |
| Mol.F. | C33H29F2N3O6 |
| Mol.Wt. | 601.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143835 |
| CAS No | NA |
| Mol.F. | C10H17N3O5 |
| Mol.Wt. | 259.26 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143836 |
| CAS No | NA |
| Mol.F. | C6H11N3O3 |
| Mol.Wt. | 173.2 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143837 |
| CAS No | NA |
| Mol.F. | C6H11N3O3 |
| Mol.Wt. | 173.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143838 |
| CAS No | NA |
| Mol.F. | C21H25N7O3 |
| Mol.Wt. | 423.48g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143839 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O4 |
| Mol.Wt. | 473.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143840 |
| CAS No | NA |
| Mol.F. | C21H24ClN7O4 |
| Mol.Wt. | 473.92 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |